Who owns PCVX?
Institutional ownership of Vaxcyte Inc. from Form 13F, Q2 2026
331 institutional managers reported holding Vaxcyte Inc. (PCVX) in Form 13F filings for Q2 2026, with 167,366,442 shares worth $9.7B. The largest reported holder was FMR LLC. Managers that filed both quarters added a net 3,399,521 shares (+2.3%). 46 opened new positions and 49 sold out.
- Funds holding
- 331
- Value held
- $9.7B
- New / sold out
- 46 / 49
- Net shares, same filers
- +2.3%
Holdings as of June 30, 2026, the end of Q2 2026. Managers have 45 days after a quarter ends to file Form 13F (by August 14, 2026 for Q2 2026), so positions may have changed since.
Largest holders of PCVX
| Fund | Value | Share of 13F holdings | Shares | Move |
|---|---|---|---|---|
| FMR LLC | $1.2B | 12.5% | 20,852,907 | Added |
| Jupiter Topco LLC | $1.0B | 10.7% | 17,965,847 | First report |
| T. Rowe Price Investment Management, Inc. | $710M | 7.3% | 12,207,450 | Added |
| BlackRock, Inc. | $702M | 7.2% | 12,068,129 | Added |
| Ra Capital Management, L.p. | $667M | 6.9% | 11,474,599 | Unchanged |
| Wellington Management Group LLP | $407M | 4.2% | 7,001,565 | Added |
| Vanguard Portfolio Management LLC | $383M | 3.9% | 6,593,551 | Added |
| Vanguard Capital Management LLC | $369M | 3.8% | 6,348,679 | Added |
| State Street Corp | $311M | 3.2% | 5,351,698 | Added |
| Deep Track Capital, LP | $250M | 2.6% | 4,300,000 | Unchanged |
| Geode Capital Management, LLC | $201M | 2.1% | 3,459,363 | Added |
| Price T Rowe Associates Inc | $174M | 1.8% | 2,988,999 | Added |
| Kynam Capital Management, LP | $170M | 1.7% | 2,922,335 | Unchanged |
| Westfield Capital Management Co LP | $144M | 1.5% | 2,472,428 | Trimmed |
| Caligan Partners LP | $127M | 1.3% | 2,188,636 | Added |
| Paradigm Biocapital Advisors LP | $124M | 1.3% | 2,127,852 | Trimmed |
| Bellevue Group AG | $115M | 1.2% | 1,971,935 | Added |
| D. E. Shaw & Co., Inc. | $111M | 1.1% | 1,901,872 | Trimmed |
| Maverick Capital LTD | $93.8M | 1.0% | 1,613,242 | Added |
| Charles Schwab Investment Management Inc | $85.1M | 0.9% | 1,464,812 | Added |
| Pivotal bioVenture Partners Investment Advisor LLC | $82.9M | 0.9% | 1,425,470 | Added |
| Eventide Asset Management, LLC | $80.2M | 0.8% | 1,380,219 | Added |
| Goldman Sachs Group Inc | $78.5M | 0.8% | 1,350,760 | Added |
| Northern Trust Corp | $74.4M | 0.8% | 1,280,172 | Added |
| Norges Bank | $72.4M | 0.7% | 1,245,805 | New |
Share of 13F holdings is each fund's shares as a share of the 167,366,442 PCVX shares all 13F filers reported, not of shares outstanding.
Biggest buyers in Q2 2026
- FMR LLC Added+$253M
- Price T Rowe Associates Inc Added+$117M
- Wellington Management Group LLP Added+$80.6M
- Norges Bank New+$72.4M
- BlackRock, Inc. Added+$63.7M
- State Street Corp Added+$53.0M
- Dimensional Fund Advisors LP Added+$47.6M
- Bellevue Group AG Added+$45.4M
- Clearbridge Investments, LLC Added+$36.3M
- Adage Capital Partners GP, L.l.c. Added+$30.8M
Biggest sellers in Q2 2026
- Paradigm Biocapital Advisors LP Trimmed-$155M
- Farallon Capital Management, L.l.c. Sold out-$73.3M
- Jennison Associates LLC Trimmed-$71.0M
- Westfield Capital Management Co LP Trimmed-$68.2M
- D. E. Shaw & Co., Inc. Trimmed-$56.0M
- Assenagon Asset Management S.A. Trimmed-$55.9M
- Baupost Group LLC Sold out-$46.5M
- Trails Edge Capital Partners, LP Sold out-$38.5M
- Jones Hill Capital LP Sold out-$37.5M
- Point72 Asset Management, L.P. Sold out-$36.1M
The change in shares since the quarter before, adjusted for stock splits and priced at the Q2 2026 value per share. Funds bought $1.2B and sold $976M; 131 added and 99 trimmed.
Schedule 13D and 13G filings on PCVX
Owners of more than 5% must file within days, so these can be newer than the 13F data.
- 2025-11-14T. Rowe Price Investment Management, Inc. SCHEDULE 13G filed by Vaxcyte Inc.Schedule 13G
Questions about PCVX ownership
- Who owns PCVX stock?
- 331 institutional investment managers reported PCVX positions in their Form 13F filings for Q2 2026, holding 167,366,442 shares worth $9.7B in total. FMR LLC reported the largest position.
- Are funds buying or selling PCVX?
- In Q2 2026, 46 managers opened new PCVX positions, 131 added, 99 trimmed and 49 sold out. Managers that filed in both quarters added a net 3,399,521 shares.
- How current is this PCVX institutional ownership data?
- It covers holdings as of the end of Q2 2026. Managers have 45 days after the quarter ends to file Form 13F (by August 14, 2026 for Q2 2026), so positions may have changed since.
From the SEC's Form 13F data sets for Q2 2026: every 13F holdings report, matched to PCVX by CUSIP. Options are left out. PCVX news and filings · PCVX insider trades · Top funds